Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

IVC filter recalled due to injury risk
Customers are urged to stop using these devices right away.
FDA clears TAVR guidewire built with BASILICA in mind
The Telltale system was designed to assist cardiologists when BASILICA is required prior to TAVR.
Canon introduces new combined CT-angiography interventional system
Jaimin Chung, director of Canon Medical’s interventional X-ray and vascular business unit, explains the technology behind a new combined CT angiography interventional system aimed at neurology, trauma, stroke and pediatrics that recently received 510(k) FDA clearance.
AI dramatically improves the detection of severe heart attacks
Researchers put an advanced AI model to the test, using it to evaluate the ECG results of more than 1,000 patients. It performed quite well.
FDA clears new-look robotic system from Stereotaxis
GenesisX represents the company’s most accessible robotic system to date. It requires no room shielding or structural anchoring, for example, and the size has been significantly reduced.

healthcare value value-based care money dollar

Boston Scientific finalizes acquisition of Baylis Medical with $1.75B payment

The deal, first announced in October 2021, expands Boston Scientific’s structural heart disease and electrophysiology portfolios by a significant margin.

Part of the cath lab case report from Fujifilm Synapse Cardiovascular. This CVIS was ranked Best in KLAS in 2022 based on user interviews.

Best of KLAS 2022: The top cardiovascular information systems and hemodynamic solutions

KLAS Research released its 2022 Best in KLAS report, which includes cardiovascular information systems and hemodynamic systems.

Ticagrelor alone after DAPT lowers bleeding risk among heart attack patients undergoing PCI

Researchers examined data from the TWILIGHT study to track how different treatment strategies can impact 12-month PCI outcomes.

New risk score predicts mortality after TEER

Researchers developed the new algorithm by identifying eight key factors associated with mortality among TEER patients.

Office-based cath lab setting proves safe for iliac vein stenting

Iliac vein stunting procedures performed in out-patient office-based labs are associated with low complication rates.

Polymer-free amphilimus-eluting stents comparable to drug-eluting stents—and offer a potential advantage

The team's evaluation included data from four different randomized controlled trials.

The Corvia Atrial Shunt is designed to address elevated left atrial pressure (LAP) heart failure patients.

Implantable atrial shunt therapy trial identifies treatable HFpEF patients

The REDUCE LAP-HF II study identified heart failure patients who may benefit from receiving a new transcatheter implant manufactured by Corvia Medical.

Continued anticoagulation after primary PCI boosts survival among STEMI patients

A key takeaway from the group's analysis was that the rate of major bleeding events did not significantly change.

Cath Lab

IVC filter recalled due to injury risk

FDA clears TAVR guidewire built with BASILICA in mind

Canon introduces new combined CT-angiography interventional system

AI dramatically improves the detection of severe heart attacks

FDA clears new-look robotic system from Stereotaxis